News

October 7, 2021
Asahi Kasei Pharma to solicit proposals for drug discovery research
September 30, 2021
Asahi Kasei Pharma files application for approval to manufacture and sell AK1820 (isavuconazonium sulfate) in Japan
September 30, 2021
Asahi Kasei Pharma obtains exclusive option for AGN1 LOEP Hip Kit
July 19, 2021
Sanofi and Asahi Kasei Pharma execute a marketing license agreement to transfer sales right in Japan for Plaquenil® Tablets 200 mg, an immunomodulator
January 29, 2021
Lilly and Asahi Kasei Pharma Announce License Agreement for Chronic Pain Drug Candidate
October 13, 2020
Asahi Kasei Pharma to solicit proposals for drug discovery research
June 2, 2020
Asahi Kasei Pharma obtains Chinese approval for Flivas™ (naftopidil) dysuria treatment
March 19, 2020
Asahi Kasei Pharma concludes license agreement with SBI Biotech for SBI-3150
January 9, 2020
Denial of motion for preliminary injunction requesting continuous supply of XIAFLEX® injection
November 27, 2019
Announcement of listing on the NHI drug price standard and marketing of Teribone™ 28.2 µg subcutaneous autoinjector
November 25, 2019
Asahi Kasei to Acquire Veloxis Pharmaceuticals Inc.
November 25, 2019
Asahi Kasei Pharma licenses fasudil to Woolsey Pharmaceuticals
October 30, 2019
Asahi Kasei Pharma to solicit proposals for drug discovery research
October 1, 2019
Filing of Complaint for Injunctive Relief requesting for continuous supply of "XIAFLEX® injection"
September 20, 2019
Approval to manufacture and sell Teribone™ autoinjector
August 2, 2019
Future plan for global Phase III clinical study of ART-123
February 21, 2019
Maruho and Asahi Kasei Pharma Announce First Approval in Japan of an Additional Dosage and Administration for Anti-herpes Virus Agent "Famvir® Tab 250 mg" for the Treatment of Recurrent Herpes Simplex (Herpes labialis/Herpes genitalis)
January 28, 2019
Asahi Kasei Pharma launching legionella kit Ribotest™ Legionella
December 17, 2018
Asahi Kasei Pharma to solicit proposals for drug discovery research
December 11, 2018
Asahi Kasei Pharma launches Kevzara® autoinjector for treatment of rheumatoid arthritis
Page Top